(Q41389065)

30 September 2017

title

Lung deposition and cellular uptake behavior of pathogen-mimicking nanovaccines in the first 48 hours (English)

1 reference

30 September 2017

Kathleen A Ross

1

1 reference

30 September 2017

Shannon L Haughney

2

1 reference

30 September 2017

Latrisha K Petersen

3

1 reference

30 September 2017

Paola Boggiatto

4

1 reference

30 September 2017

Michael J Wannemuehler

5

1 reference

30 September 2017

Balaji Narasimhan

6

1 reference

30 September 2017

publication date

12 February 2014

1 reference

Advanced Healthcare Materials

30 September 2017

published in

1 reference

30 September 2017

volume

3

1 reference

30 September 2017

issue

7

1 reference

30 September 2017

page(s)

1071-1077

1 reference

Nanoparticles for nasal vaccination.

30 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300525

21 January 2018

Nasal vaccine innovation

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300525

Pharmaceutical aspects of intranasal delivery of vaccines using particulate systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300525

Development and characterization of chitosan coated poly-(ɛ-caprolactone) nanoparticulate system for effective immunization against influenza.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300525

Design of a protective single-dose intranasal nanoparticle-based vaccine platform for respiratory infectious diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300525

Evaluation of biocompatibility and administration site reactogenicity of polyanhydride-particle-based platform for vaccine delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300525

Activation of innate immune responses in a pathogen-mimicking manner by amphiphilic polyanhydride nanoparticle adjuvants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300525

Rational design of pathogen-mimicking amphiphilic materials as nanoadjuvants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300525

Review of aerosol transmission of influenza A virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300525

Aerosol vaccination induces robust protective immunity to homologous and heterologous influenza infection in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300525

Visualizing the first 50 hr of the primary immune response to a soluble antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300525

Vaccine adjuvants: current challenges and future approaches.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300525

Single dose vaccine based on biodegradable polyanhydride microspheres can modulate immune response mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300525

Amphiphilic polyanhydrides for protein stabilization and release

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300525

The delivery site of a monovalent influenza vaccine within the respiratory tract impacts on the immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300525

21 January 2018

Identifiers

DOI

10.1002/ADHM.201300525

1 reference

30 September 2017

1 reference